Filling the Analysis Gap in the Move to Continuous Processing

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-15-2016
Volume 2016 eBook
Issue 1
Pages: s34-s37

The author discusses issues and best approaches for solid dosage form pharmaceuticals.

More pharmaceutical companies are becoming interested in continuous processing, but they may face an “analytics gap,” because continuous will require a different approach to analytics. The author discusses issues and best approaches for solid dosage form pharmaceuticals.

Read this article

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the

2016 Solid Dosage Drug Development and Manufacturing eBook.
Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Related Content